Open to opportunities

Kaouthar Louati

@kaoutharlouati

Research associate pharmacist specializing in analytical chemistry, mass spectrometry, and cancer-focused proteomics for safer drug development.

Tunisia

Message

What I'm looking for

I’m looking for a research-focused role where I can lead analytical and mass-spectrometry-based studies (proteomics/toxicoproteomics) to support cancer discovery and drug development, in a rigorous, quality-driven environment.

I’m a Doctor Pharmacist and Associate Researcher in the Laboratory of Pharmacology, Analytics and Galenic Drug Development, with expertise spanning analytical chemistry, drugs’ control and development, and toxicological analysis. I focus on chromatographic and mass spectrometry techniques to support cancer-oriented research and advancing treatment strategies.

In my current role (01/2020–Present), I apply toxicoproteomics and proteomics approaches using cell culture models, 2D-SDS-PAGE, and Nano-UHPLC-MS/MS. I also use bioinformatics for genomics to identify prognostic biomarkers implicated in cancer, leveraging tools such as STRING, PANTHER, METASCAPE, and CYTOSACPE.

Previously, as a Research Associate at UNIMED LABORATORIES and PHARMACARE LABORATORIES (01/2010–2015), I contributed to pharmaceutical generic drug development and drug control following European, American, and British Pharmacopeias. I developed stability-indicating and purity control analytical methods, performed stress degradation studies, and ensured analytical validation aligned with ICH Q2R1 and Q3B, while supporting stability studies and batch release through rigorous reporting.

Experience

Work history, roles, and key accomplishments

Current

Doctor Pharmacist & Associate

Current

University of Monastir

Jan 2020 - Present (6 years 5 months)

Conducted toxicoproteomics and proteomics research using cell culture models and nano-UHPLC-MS/MS to assess oxidative stress and pesticide-related protein damage and adduct formation, including PTM mapping. Performed genomics-focused bioinformatics analyses to identify prognostic biomarker genes in cancer using STRING, PANTHER, METASCAPE, and Cytoscape.

Nano UHPLC MS MS Proteomics Bioinformatics Panther Cytoscape

Pharmacist Research Associate

Unimed Laboratories

Jan 2010 - Jan 2015 (5 years)

Contributed to the development of pharmaceutical generic drugs and performed control of raw materials and APIs according to European, American, and British Pharmacopeias. Developed stability-indicating and purity analytical methods and executed ICH Q2(R1)/Q3B validations, along with ICH Q1A(R2) stability studies.

ICH Q2(R1) Validation ICH Q3B Impurity Control GC MS

Analytical Methods Associate

Pharmacare Laboratories

Jan 2010 - Jan 2015 (5 years)

Supported development and testing of pharmaceutical products by performing separation of drug substances from impurities/degradation compounds using chromatographic methods. Produced analytical validation and stability study documentation and supported sampling for beginning, intermediate, and finished products to assist batch release decisions.

Chromatographic Methods ICH Q2(R1) Parameters ICH Q3B Parameters ICH Q1A(R2) Stability Protocols HPLC UHPLC Method Interpretation UV Mass Spectrometry Detectors

Education

Degrees, certifications, and relevant coursework

University of Monastir, Faculty of Pharmacy

Doctoral Thesis, Analytical Chemistry

2019 - 2024

Completed a doctoral thesis in Analytical Chemistry at the University of Monastir, Faculty of Pharmacy. Received very honorable academic awards.

University of Monastir, Faculty of Pharmacy

Master degree, Medicaments’ Research and Development

2009 - 2010

Earned a master degree in Medicaments’ Research and Development at the University of Monastir, Faculty of Pharmacy. Received very honorable academic awards.